The European Commission on Thursday said it had fined five pharmaceutical companies for a total of 13.4 million euros ($14.1 million) in a settlement of an antitrust investigation.

The commission fined Alkaloids of Australia, Alkaloids Corporation, Boehringer, Linnea and Transo-Pharm for participating in a cartel aimed at fixing the minimum price of an ingredient to produce the abdominal antispasmodic drug Buscopan and its generic versions.

($1 = 0.9489 euros) (Reporting by Bart Meijer, Editing by Charlotte Van Campenhout)